- Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan et al, 2017, Chemical Reviews CrossRef - Physicochemical Characterization and Biopharmaceutical Evaluation of ZWF: A Novel Anticancer Drug for the Treatment of Non-small Cell Lung Cancer
Lina Zhao et al, 2021, AAPS PharmSciTech CrossRef - Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway
Liwei Jia et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef - Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer
Xiaoying Pang et al, 2019, Journal of Drug Delivery Science and Technology CrossRef - Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
Andrew Sulaiman et al, 2020, International Journal of Molecular Sciences CrossRef - Precision medicine in gastric cancer
Patrizia Bonelli et al, 2019, World Journal of Gastrointestinal Oncology CrossRef - SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
Surya Kant Tripathi et al, 2021, Life Sciences CrossRef - Rhein Inhibits the Progression of Chemoresistant Lung Cancer Cell Lines via the Stat3/Snail/MMP2/MMP9 Pathway
Jinxin Liu et al, 2022, BioMed Research International CrossRef